Rosmarin, David http://orcid.org/0000-0003-2786-0708
Lofland, Jennifer H. http://orcid.org/0000-0002-1015-3823
Marwaha, Simran http://orcid.org/0000-0003-0380-0372
Piercy, James http://orcid.org/0000-0001-7015-1021
Anderson, Peter http://orcid.org/0000-0002-2171-8228
Liu, Jinan http://orcid.org/0009-0002-6042-5476
Funding for this research was provided by:
Incyte
Article History
Received: 8 February 2024
Accepted: 10 April 2024
First Online: 16 May 2024
Declarations
:
: David Rosmarin has received honoraria as a consultant for AbbVie, Abcuro, AltruBio, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Concert, Dermavant Sciences, Dermira, Incyte Corporation, Janssen, Kyowa Kirin, Lilly, Novartis, Pfizer, Regeneron Pharmaceuticals, Revolo Biotherapeutics, Sanofi, Sun Pharmaceuticals, UCB, and Viela Bio; has received research support from AbbVie, Amgen, Bristol Myers Squibb, Celgene, Dermira, Galderma, Incyte Corporation, Janssen, Lilly, Merck, Novartis, Pfizer, and Regeneron Pharmaceuticals; and has served as a paid speaker for AbbVie, Amgen, Celgene, Janssen, Lilly, Novartis, Pfizer, Regeneron Pharmaceuticals, and Sanofi. Jennifer H. Lofland and Jinan Liu are employees and stockholders of Incyte Corporation. Simran Marwaha, James Piercy, and Peter Anderson are employees of Adelphi Group, which was contracted by Incyte Corporation to perform this analysis.
: The Adelphi Vitiligo Disease Specific Programme™ received ethics exemption from the Pearl Institutional Review Board (study protocol number #21-ADRW-122) based on the use of aggregated and de-identified patient data. All data were collected in such a way that patients and dermatologists could not be identified directly; all data were aggregated and de-identified before receipt. Each survey was performed in full accordance with relevant legislation at the time of data collection, including the US Health Insurance Portability and Accountability Act of 1996 and Health Information Technology for Economic and Clinical Health Act legislation. Both physicians and patients consented to take part in the research.